CPT code 87520 designates a laboratory molecular diagnostic test that uses a direct nucleic acid probe technique to detect hepatitis C viral material. This diagnostic procedure is important for confirming active hepatitis C infection, guiding clinical management, and supporting public health surveillance. Molecular confirmation of hepatitis C remains a critical component of hepatitis C care pathways and is widely performed in clinical and hospital laboratory settings.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of what CPT code 87520 represents, payer coverage patterns, and the clinical context for use. The publication outlines where this service is typically performed, common billing modifiers and service-line considerations, and links to related laboratory coding practices.

This summary provides the essential coding description and service context; detailed benchmarks, policy updates, and payer-specific coverage nuances are presented in the main publication. Data not available in the input is noted where applicable.